Evidence map›Paper›PMID 31172633›Full record

ArticlePharmacoepidemiology and drug safety2019

Validity of ICD-9 and ICD-10 codes used to identify acute liver injury: A study in three European data sources.

Joan Forns, Miguel Cainzos-Achirica, Maja Hellfritzsch, Rosa Morros, Beatriz Poblador-Plou, Jesper Hallas, Maria Giner-Soriano, Alexandra Prados-Torres, Anton Pottegård, Jordi Cortés and 5 more

Abstract readValidation Study
In one paragraph

Article in Pharmacoepidemiology and drug safety, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Reply to Rezahosseini.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2022
    Article
  6. Oral Fluoroquinolone Use and the Risk of Acute Liver Injury: A Nationwide Cohort Study.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2022
    Article
  7. Article
  8. Article
  9. Observational
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Joan FornsEpidemiology, RTI Health Solutions, Barcelona, Spain.ORCID 0000-0002-1066-0358
Miguel Cainzos-AchiricaEpidemiology, RTI Health Solutions, Barcelona, Spain.ORCID 0000-0002-3805-9089
Maja HellfritzschClinical Pharmacology and Pharmacy, Department of Public Health, University of Southern Denmark, Odense, Denmark.
Rosa MorrosFundació Institut Universitari per a la recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain.
Beatriz Poblador-PlouEpiChron Research Group. Aragon Health Sciences Institute (IACS), IIS Aragón, REDISSEC ISCIII, Zaragoza, Spain.
Jesper HallasClinical Pharmacology and Pharmacy, Department of Public Health, University of Southern Denmark, Odense, Denmark.ORCID 0000-0002-8097-8708
Maria Giner-SorianoFundació Institut Universitari per a la recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain.ORCID 0000-0003-3750-9233
Alexandra Prados-TorresEpiChron Research Group. Aragon Health Sciences Institute (IACS), IIS Aragón, REDISSEC ISCIII, Zaragoza, Spain.
Anton PottegårdClinical Pharmacology and Pharmacy, Department of Public Health, University of Southern Denmark, Odense, Denmark.ORCID 0000-0001-9314-5679
Jordi CortésDepartament d'Estadística i Investigació Operativa, Universitat Politècnica de Catalunya, Barcelona, Spain.
Jordi CastellsaguéEpidemiology, RTI Health Solutions, Barcelona, Spain.
Emmanuelle JacquotPharmacoepidemiology Department, Les Laboratoires Servier, Paris, France.
Nicolas DeltourPharmacoepidemiology Department, Les Laboratoires Servier, Paris, France.
Susana Perez-GutthannEpidemiology, RTI Health Solutions, Barcelona, Spain.
Manel PladevallEpidemiology, RTI Health Solutions, Barcelona, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeValidating cases of acute liver injury (ALI) in health care data sources is challenging. Previous validation studies reported low positive predictive values (PPVs).

methodsCase validation was undertaken in a study conducted from 2009 to 2014 assessing the risk of ALI in antidepressants users in databases in Spain (EpiChron and SIDIAP) and the Danish National Health Registers. Three ALI definitions were evaluated: primary (specific hospital discharge codes), secondary (specific and nonspecific hospital discharge codes), and tertiary (specific and nonspecific hospital and outpatient codes). The validation included review of patient profiles (EpiChron and SIDIAP) and of clinical data from medical records (EpiChron and Denmark). ALI cases were confirmed when liver enzyme values met a definition by an international working group.

resultsOverall PPVs (95% CIs) for the study ALI definitions were, for the primary ALI definition, 84% (60%-97%) (EpiChron), 60% (26%-88%) (SIDIAP), and 74% (60%-85%) (Denmark); for the secondary ALI definition, 65% (45%-81%) (EpiChron), 40% (19%-64%) (SIDIAP), and 70% (64%-77%) (Denmark); and for the tertiary ALI definition, 25% (18%-34%) (EpiChron), 8% (7%-9%) (SIDIAP), and 47% (42%-52%) (Denmark). The overall PPVs were higher for specific than for nonspecific codes and for hospital discharge than for outpatient codes. The nonspecific code "unspecified jaundice" had high PPVs in Denmark.

conclusionsPPVs obtained apply to patients using antidepressants without preexisting liver disease or ALI risk factors. To maximize validity, studies on ALI should prioritize hospital specific discharge codes and should include hospital codes for unspecified jaundice. Case validation is required when ALI outpatient cases are considered.

Indexed as

Databases, FactualAdolescentAdultAgedAged, 80 and overChemical and Drug Induced Liver InjuryDenmarkDiagnosis-Related GroupsFemaleHumansMaleMiddle AgedPharmacoepidemiologyReproducibility of ResultsSpainYoung Adultacute liver injuryantidepressantspharmacoepidemiologyvalidation

Identifiers

PMID31172633
PMCPMC6618105

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.